Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Southeast Asia Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Diabetes Clinics/Centers), By End Use (Diagnostic Centers, Homecare), And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.
The Southeast Asia diabetes devices market size is anticipated to reach USD 3.58 billion by 2030, registering a CAGR of 9.36% from 2024 to 2030
The market is growing due to the rising occurrence of diabetes linked to aging, obesity, and poor lifestyle choices. Obesity rates in SEA have surged by 40% from 1990 to 2013. Forecasts indicate that by 2030, over 52.4 million adults and 21 million youth in the region will be obese. As obesity rates continue to increase in the region, the incidence of diabetes is also expected to rise, driving the demand for effective diabetes management devices. The excessive body fat associated with obesity can lead to insulin resistance, a contributor to the onset of diabetes, further exacerbating the already high prevalence of the disease in Southeast Asia.
Diabetes devices play a pivotal role in enhancing the care and management of diabetic patients. The growing demand for these devices is driven by their ability to prevent prolonged hospital stays and reduce mortality rates among individuals with diabetes. The proactive approach enabled by diabetes devices can help prevent serious complications associated with uncontrolled blood sugar levels. By allowing for early detection of hypo- or hyperglycemia, these devices enable prompt action to stabilize glucose levels before they escalate into critical situations. This proactive monitoring can significantly reduce the risk of diabetic emergencies requiring hospitalization, ultimately improving patient outcomes and quality of life.
Increasing awareness about diabetes management through educational campaigns and programs plays a vital role in driving market growth. Educating patients about the importance of regular monitoring and adherence to treatment regimens boosts the demand for related medical devices. For instance, in April 2024, Embecta, a New Jersey company, launched a diabetes education program named emERGE in the Asia-Pacific region.
The program is set to commence in 11 countries, including Singapore, Thailand, Vietnam, Australia, South Korea, Japan, Indonesia, Malaysia, the Philippines, and New Zealand. The primary goal of this initiative is to provide educational benefits to around 5,000 healthcare professionals, such as practitioners, diabetes nurse educators, and lead pharmacists, through a series of four interactive webinars.
Southeast Asia Diabetes Devices Market Report Highlights
- In 2023, the insulin delivery devices segment dominated the market with a share of over 50.00% and is expected to grow over the forecast period due to patient preferences, treatment outcomes, and healthcare professional recommendations
- Based on distribution channels, the hospital pharmacies segment held the largest share of around 53.00% in 2023. This can be attributed to the accessibility of hospital pharmacies to patients who visit healthcare facilities for various needs, including diabetes management
- The retail pharmacies segment is expected to grow at the fastest CAGR during the forecast period due to the expanding network of retail pharmacies in the region
- The hospital pharmacy end use segment held a majority share of the market of over 40.00% in 2023. This is attributed to the number of patients with diabetes being hospitalized
- The diagnostic centers segment is expected to grow at the fastest CAGR over the forecast period due to their ability to provide quick and accurate results
Companies Featured
- Abbott Laboratories
- Arkray, Inc.
- B Braun Melsungen AG
- Bayer AG
- Companion Medical
- Dexcom Inc.
- F.Hoffmann-La-Ltd.
- Insulet Corporation
- Lifescan, Inc.
- Medtronic plc
- Novo Nordisk
- Sanofi
- Valeritas Holding Inc.
- Ypsomed Holdings
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End Use outlook
2.3. Competitive Insights
Chapter 3. Southeast Asia Diabetes Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase in diabetic prevalence
3.2.1.2. Technological advancements
3.2.1.3. Initiatives by government organizations and NGOs
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations policies and regulations
3.2.2.2. High cost of devices
3.3. Southeast Asia Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Southeast Asia Diabetes Devices Market: Type Estimates & Trend Analysis
4.1. Modality Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Southeast Asia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5. BGM Devices
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Monitoring Devices
4.5.2.3. Testing Strips
4.5.2.4. Lancets
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.3. Transmitter
4.5.3.4. Receiver
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Pumps
4.6.3. Pens
4.6.4. Syringes
4.6.5. Jet Injector
Chapter 5. Southeast Asia Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Southeast Asia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospital Pharmacies
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Retail Pharmacies
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Diabetes Clinics/Centers
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.3. Online Pharmacies
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.4. Others
5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Southeast Asia Diabetes Devices Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Southeast Asia Diabetes Devices Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4.1. Hospitals
6.4.2. Diagnostic Centers
6.4.3. Homecare
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Product benchmarking
7.4.4. Strategic initiatives
For more information about this report visit https://www.researchandmarkets.com/r/6jk5j4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
